Trial Profile
A six-month, double-blind, placebo controlled, durability of effect study of pregabalin for pain associated with fibromyalgia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Acronyms FREEDOM
- 09 Oct 2007 Results were reported at the 18th Annual Meeting of the North American Menopause Society.
- 05 May 2007 Results have been reported.
- 22 Sep 2006 Status change